XLV RSI
State Street Health Care Select Sector SPDR ETF
XLV offers concentrated exposure to the S&P 500 healthcare sector, covering everything from pharmaceutical giants to biotech innovators in one liquid, low-cost investment vehicle.
Historical oversold levels
Track when XLV has reached oversold conditions (RSI below 30) historically. These levels often present potential buying opportunities.
XLV RSI has never been oversold on the weekly timeframe
What is XLV?
XLV was launched in December 1998 by State Street Global Advisors as part of the original suite of Select Sector SPDR ETFs. It was created to provide investors with a low-cost, transparent tool to gain exposure to the healthcare sector of the S&P 500. This fund effectively bridges the gap between active trading and passive indexing by focusing on one of the most essential and resilient sectors of the global economy.
The core business model of XLV is built on passive replication. The fund tracks the Health Care Select Sector Index, which includes massive players in pharmaceuticals, healthcare equipment and supplies, healthcare providers and services, and biotechnology. By holding heavyweights like UnitedHealth Group, Johnson & Johnson, and Eli Lilly, the fund offers a balanced mix of stable dividend payers and high-growth innovators. It is a preferred vehicle for both institutional and retail investors due to its deep liquidity and extremely competitive expense ratio.
Historically, XLV has reached significant milestones, including navigating the implementation of the Affordable Care Act and the rapid vaccine development cycle during the COVID-19 pandemic. These periods solidified the fund's reputation as a reliable defensive play during market volatility while still capturing significant upside during medical breakthroughs. Financially, it remains one of the largest sector ETFs in the world, with assets under management typically exceeding $35 billion, which ensures tight bid-ask spreads for traders.
Looking toward 2026, the strategic outlook for XLV is driven by two main factors: demographic shifts and technological leaps. The aging global population ensures a steady floor for healthcare demand, while the commercialization of GLP-1 weight-loss medications and AI-driven drug discovery provide massive growth catalysts. By 2026, we expect to see a surge in M&A activity as pharmaceutical giants use their cash reserves to buy up biotech firms to combat upcoming patent expirations. This makes XLV a solid bet for capturing the next wave of healthcare evolution.
What is RSI?
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and magnitude of price changes. Developed by J. Welles Wilder, RSI ranges from 0 to 100 and helps traders identify overbought or oversold conditions in an asset.
For XLV, monitoring the RSI provides valuable insights into potential trend reversals and entry/exit points. When the RSI drops below 30, State Street Health Care Select Sector SPDR ETF is typically considered oversold, suggesting the asset may be undervalued. Conversely, an RSI above 70 indicates overbought conditions.
Understanding XLV RSI Signals
- Oversold (RSI below 30): When XLV RSI falls below 30, it suggests the asset may have been sold off excessively and could be due for a bounce. This is often viewed as a potential buying opportunity, though it's important to consider other factors and not rely solely on RSI.
- Overbought (RSI above 70): An RSI above 70 indicates XLV may be overbought, potentially signaling a pullback or consolidation phase. Traders often use this as a signal to take profits or wait for better entry points.
- Divergences: When XLV price makes new highs or lows but RSI doesn't confirm these moves, it can signal weakening momentum and a possible trend reversal.
Daily vs Weekly RSI for XLV
This page displays both daily and weekly RSI for XLV. The daily RSI responds quickly to short-term price movements, making it useful for day traders and swing traders. The weekly RSI provides a broader perspective on momentum trends, helping longer-term investors identify major oversold or overbought conditions.
By analyzing both timeframes together, you can better understand State Street Health Care Select Sector SPDR ETF's momentum at multiple levels and make more informed trading decisions.
Historical RSI Oversold Analysis
Above, we track historical instances when XLV RSI dropped below 30 (oversold territory). Reviewing these past oversold levels helps identify patterns and understand how State Street Health Care Select Sector SPDR ETF has historically responded to oversold conditions. Many traders use these historical reference points to gauge potential support levels and timing for entry positions.
Assets with similar RSI
Assets currently trading with RSI levels close to XLV